Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ROCK alpha-aqua trial
jRCTs051240091Active, not recruiting
- Sponsor
- Kowa Company, Ltd.
- Start
- Aug 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of ripasudil, brimonidine and latanoprost in ocular hypertension and Glaucoma (3 arms), sponsored by Kowa Company, Ltd. Started Aug 2024; status: active, not recruiting.
02
Drugs
ripasudilbrimonidinelatanoprost
03
Conditions
ocular hypertensionGlaucoma
Beyond the preview
Go deeper on jRCTs051240091.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051240091.